Celastrol in cancer therapy: Recent developments, challenges and prospects

10.1016/j.canlet.2021.08.030

Saved in:
Bibliographic Details
Main Authors: Lim, Hannah Ying, PEI SHI ONG, LINGZHI WANG, Goel, Arul, LINGWEN DING, LI ANN ANDREA WONG, Ho P.C., Sethi, Gautam, Xiang, Xiaoqiang, Goh, B.C.
Other Authors: MEDICINE
Format: Article
Language:English
Published: ELSEVIER IRELAND LTD 2021
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/204075
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-204075
record_format dspace
spelling sg-nus-scholar.10635-2040752024-04-17T09:55:55Z Celastrol in cancer therapy: Recent developments, challenges and prospects Lim, Hannah Ying PEI SHI ONG LINGZHI WANG Goel, Arul LINGWEN DING LI ANN ANDREA WONG Ho P.C. Sethi, Gautam Xiang, Xiaoqiang Goh, B.C. MEDICINE PATHOLOGY PHARMACOLOGY PHARMACY Science & Technology Life Sciences & Biomedicine Oncology Celastrol Anti-cancer activity Pharmacokinetics Toxicity Translational potential STAT3 SIGNALING PATHWAY KAPPA-B KINASE HEPATOCELLULAR-CARCINOMA IN-VITRO NUDE-MICE ANTICANCER ACTIVITY HSP90 INHIBITOR PURE CELASTROL TUMOR-GROWTH HUMAN GLIOMA 10.1016/j.canlet.2021.08.030 CANCER LETTERS 521 252-267 2021-10-25T00:45:16Z 2021-10-25T00:45:16Z 2021-11-28 2021-10-22T10:21:44Z Article Lim, Hannah Ying, PEI SHI ONG, LINGZHI WANG, Goel, Arul, LINGWEN DING, LI ANN ANDREA WONG, Ho P.C., Sethi, Gautam, Xiang, Xiaoqiang, Goh, B.C. (2021-11-28). Celastrol in cancer therapy: Recent developments, challenges and prospects. CANCER LETTERS 521 : 252-267. ScholarBank@NUS Repository. https://doi.org/10.1016/j.canlet.2021.08.030 0304-3835 1872-7980 https://scholarbank.nus.edu.sg/handle/10635/204075 en ELSEVIER IRELAND LTD Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Oncology
Celastrol
Anti-cancer activity
Pharmacokinetics
Toxicity
Translational potential
STAT3 SIGNALING PATHWAY
KAPPA-B KINASE
HEPATOCELLULAR-CARCINOMA
IN-VITRO
NUDE-MICE
ANTICANCER ACTIVITY
HSP90 INHIBITOR
PURE CELASTROL
TUMOR-GROWTH
HUMAN GLIOMA
spellingShingle Science & Technology
Life Sciences & Biomedicine
Oncology
Celastrol
Anti-cancer activity
Pharmacokinetics
Toxicity
Translational potential
STAT3 SIGNALING PATHWAY
KAPPA-B KINASE
HEPATOCELLULAR-CARCINOMA
IN-VITRO
NUDE-MICE
ANTICANCER ACTIVITY
HSP90 INHIBITOR
PURE CELASTROL
TUMOR-GROWTH
HUMAN GLIOMA
Lim, Hannah Ying
PEI SHI ONG
LINGZHI WANG
Goel, Arul
LINGWEN DING
LI ANN ANDREA WONG
Ho P.C.
Sethi, Gautam
Xiang, Xiaoqiang
Goh, B.C.
Celastrol in cancer therapy: Recent developments, challenges and prospects
description 10.1016/j.canlet.2021.08.030
author2 MEDICINE
author_facet MEDICINE
Lim, Hannah Ying
PEI SHI ONG
LINGZHI WANG
Goel, Arul
LINGWEN DING
LI ANN ANDREA WONG
Ho P.C.
Sethi, Gautam
Xiang, Xiaoqiang
Goh, B.C.
format Article
author Lim, Hannah Ying
PEI SHI ONG
LINGZHI WANG
Goel, Arul
LINGWEN DING
LI ANN ANDREA WONG
Ho P.C.
Sethi, Gautam
Xiang, Xiaoqiang
Goh, B.C.
author_sort Lim, Hannah Ying
title Celastrol in cancer therapy: Recent developments, challenges and prospects
title_short Celastrol in cancer therapy: Recent developments, challenges and prospects
title_full Celastrol in cancer therapy: Recent developments, challenges and prospects
title_fullStr Celastrol in cancer therapy: Recent developments, challenges and prospects
title_full_unstemmed Celastrol in cancer therapy: Recent developments, challenges and prospects
title_sort celastrol in cancer therapy: recent developments, challenges and prospects
publisher ELSEVIER IRELAND LTD
publishDate 2021
url https://scholarbank.nus.edu.sg/handle/10635/204075
_version_ 1800915029017493504